U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Peripheral cone dystrophy

MedGen UID:
323031
Concept ID:
C1836946
Disease or Syndrome
Synonym: Peripheral Cone Dystrophy
 
Monarch Initiative: MONDO:0012174
OMIM®: 609021

Clinical features

From HPO
Pallor
MedGen UID:
10547
Concept ID:
C0030232
Finding
Abnormally pale skin.
Optic atrophy
MedGen UID:
18180
Concept ID:
C0029124
Disease or Syndrome
Atrophy of the optic nerve. Optic atrophy results from the death of the retinal ganglion cell axons that comprise the optic nerve and manifesting as a pale optic nerve on fundoscopy.
Paracentral scotoma
MedGen UID:
75740
Concept ID:
C0271197
Finding
Optic disc pallor
MedGen UID:
108218
Concept ID:
C0554970
Finding
A pale yellow discoloration of the optic disc (the area of the optic nerve head in the retina). The optic disc normally has a pinkish hue with a central yellowish depression.
Peripheral retinal degeneration
MedGen UID:
232938
Concept ID:
C1320640
Disease or Syndrome
Degeneration of the peripheral retina.
Pericentral scotoma
MedGen UID:
231156
Concept ID:
C1321308
Finding
A scotoma (area of diminished vision within the visual field) that surrounds the central fixation point.
Visual impairment
MedGen UID:
777085
Concept ID:
C3665347
Finding
Visual impairment (or vision impairment) is vision loss (of a person) to such a degree as to qualify as an additional support need through a significant limitation of visual capability resulting from either disease, trauma, or congenital or degenerative conditions that cannot be corrected by conventional means, such as refractive correction, medication, or surgery.
Cone-rod dystrophy
MedGen UID:
896366
Concept ID:
C4085590
Disease or Syndrome
The first signs and symptoms of cone-rod dystrophy, which often occur in childhood, are usually decreased sharpness of vision (visual acuity) and increased sensitivity to light (photophobia). These features are typically followed by impaired color vision (dyschromatopsia), blind spots (scotomas) in the center of the visual field, and partial side (peripheral) vision loss. Over time, affected individuals develop night blindness and a worsening of their peripheral vision, which can limit independent mobility. Decreasing visual acuity makes reading increasingly difficult and most affected individuals are legally blind by mid-adulthood. As the condition progresses, individuals may develop involuntary eye movements (nystagmus).\n\nThere are more than 30 types of cone-rod dystrophy, which are distinguished by their genetic cause and their pattern of inheritance: autosomal recessive, autosomal dominant, and X-linked. Additionally, cone-rod dystrophy can occur alone without any other signs and symptoms or it can occur as part of a syndrome that affects multiple parts of the body.\n\nCone-rod dystrophy is a group of related eye disorders that causes vision loss, which becomes more severe over time. These disorders affect the retina, which is the layer of light-sensitive tissue at the back of the eye. In people with cone-rod dystrophy, vision loss occurs as the light-sensing cells of the retina gradually deteriorate.

Recent clinical studies

Etiology

Kameya S, Fujinami K, Ueno S, Hayashi T, Kuniyoshi K, Ideta R, Kikuchi S, Kubota D, Yoshitake K, Katagiri S, Sakuramoto H, Kominami T, Terasaki H, Yang L, Fujinami-Yokokawa Y, Liu X, Arno G, Pontikos N, Miyake Y, Iwata T, Tsunoda K; Japan Eye Genetics Consortium
Invest Ophthalmol Vis Sci 2019 Aug 1;60(10):3432-3446. doi: 10.1167/iovs.19-26650. PMID: 31390656

Diagnosis

Kameya S, Fujinami K, Ueno S, Hayashi T, Kuniyoshi K, Ideta R, Kikuchi S, Kubota D, Yoshitake K, Katagiri S, Sakuramoto H, Kominami T, Terasaki H, Yang L, Fujinami-Yokokawa Y, Liu X, Arno G, Pontikos N, Miyake Y, Iwata T, Tsunoda K; Japan Eye Genetics Consortium
Invest Ophthalmol Vis Sci 2019 Aug 1;60(10):3432-3446. doi: 10.1167/iovs.19-26650. PMID: 31390656
Ito N, Kameya S, Gocho K, Hayashi T, Kikuchi S, Katagiri S, Gekka T, Yamaki K, Takahashi H, Tsuneoka H
Doc Ophthalmol 2015 Jun;130(3):241-51. Epub 2015 Feb 24 doi: 10.1007/s10633-015-9490-1. PMID: 25708979Free PMC Article
Vaphiades MS, Doyle JI
J Neuroophthalmol 2014 Dec;34(4):366-8. doi: 10.1097/WNO.0000000000000119. PMID: 24705257
Kondo M, Miyake Y, Kondo N, Ueno S, Takakuwa H, Terasaki H
Ophthalmology 2004 Apr;111(4):732-9. doi: 10.1016/j.ophtha.2003.07.005. PMID: 15051206

Prognosis

Jin X, Chen L, Wang D, Zhang Y, Chen Z, Huang H
Ophthalmic Genet 2018 Jun;39(3):300-306. Epub 2018 Jan 29 doi: 10.1080/13816810.2018.1430239. PMID: 29377742

Clinical prediction guides

Jin X, Chen L, Wang D, Zhang Y, Chen Z, Huang H
Ophthalmic Genet 2018 Jun;39(3):300-306. Epub 2018 Jan 29 doi: 10.1080/13816810.2018.1430239. PMID: 29377742
Ito N, Kameya S, Gocho K, Hayashi T, Kikuchi S, Katagiri S, Gekka T, Yamaki K, Takahashi H, Tsuneoka H
Doc Ophthalmol 2015 Jun;130(3):241-51. Epub 2015 Feb 24 doi: 10.1007/s10633-015-9490-1. PMID: 25708979Free PMC Article
Kondo M, Miyake Y, Kondo N, Ueno S, Takakuwa H, Terasaki H
Ophthalmology 2004 Apr;111(4):732-9. doi: 10.1016/j.ophtha.2003.07.005. PMID: 15051206

Supplemental Content

Table of contents

    Clinical resources

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...